Insider Transactions in Q3 2021 at Oncocyte Corp (OCX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
0
|
-
|
|
Sep 23
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
573,461
+3.2%
|
$1,720,383
$3.15 P/Share
|
|
Jul 01
2021
|
Ronald Asbury Andrews Former CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,834
-6.11%
|
-
|
|
Jul 01
2021
|
Ronald Asbury Andrews Former CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
65,000
+20.06%
|
-
|